...
首页> 外文期刊>Pharmacoepidemiology and drug safety >Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs.
【24h】

Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs.

机译:苯二氮卓类药物和老年驾驶员:药物流行病学研究设计的比较。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: Contradictory results were published from two studies in the late 1990s about the effects of long half-life benzodiazepine use on the risk of motor vehicle crashes (MVCs) in the elderly. The use of different study designs could explain the differences observed in these studies. METHODS: The results of an unmatched case-control study were compared to those of a case-crossover study using the same prescription claims database to determine whether the current use of benzodiazepines increased the risk of MVCs. RESULTS: There were 5579 cases and 12 911 controls identified between the years 1990 and 1993 in the province of Quebec, Canada. The case-control approach demonstrated an increased rate of injurious MVC associated with the current use of long-acting benzodiazepines [odds ratio (OR) 1.45; 95% confidence interval (CI): 1.12-1.88]. The case-crossover approach applied to all cases did not show any association [OR 0.99; 95%CI: 0.83-1.19]. However, among the cases restricted to subjects with four or less prescriptions filled in the previous year, corresponding more to transient exposures, the OR was elevated [OR 1.53; 95%CI: 1.08-2.16]. CONCLUSIONS: Differences in study design and analysis may explain some of the discrepancies in previous results. Both study designs provide evidence that long-acting benzodiazepines appear to be associated with an increased risk of MVC.
机译:目的:在1990年代后期发表的两项研究结果相互矛盾,有关长期使用半衰期苯二氮卓类药物对老年人发生机动车碰撞(MVC)的风险的影响。使用不同的研究设计可以解释这些研究中观察到的差异。方法:将无与伦比的病例对照研究的结果与使用相同处方药索赔数据库的病例交叉研究的结果进行比较,以确定当前使用的苯二氮卓类药物是否增加了MVC的风险。结果:1990年至1993年之间,加拿大魁北克省共鉴定出5579例病例和12 911例对照。病例对照方法证实了与长效苯二氮卓类药物的当前使用相关的伤害性MVC发生率增加[比值比(OR)为1.45; 95%置信区间(CI):1.12-1.88]。适用于所有案例的案例交叉方法未显示出任何关联[OR 0.99; 95%CI:0.83-1.19]。但是,在仅限于上一年开具四张或更少处方的受试者的情况下,对应于更多的短暂性暴露的病例中,OR升高[OR 1.53; 95%CI:1.08-2.16]。结论:研究设计和分析的差异可能解释了先前结果中的一些差异。两种研究设计均提供证据,表明长效苯并二氮杂似乎与MVC风险增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号